CASI Pharmaceuticals (CASIF) Gross Profit (2022 - 2025)
CASI Pharmaceuticals (CASIF) posted Gross Profit of $3.69 million for Q4 2025, up 14.4% from $3.23 million a year earlier and up 423.1% from the prior quarter.
Powered by 
Analysis
CASI Pharmaceuticals (CASIF) Gross Profit (2022 - 2025) Analysis & Trends
For FY2025, CASI Pharmaceuticals' Gross Profit came in at $10.08 million, down 9.6% from FY2024.
- Annual Gross Profit has declined for three consecutive years, though with a five-year compound annual growth rate of 12.3% (FY2020 to FY2025).
- In prior years, CASI Pharmaceuticals' Gross Profit was $11.15 million in FY2024 (-44.4%), $20.05 million in FY2023 (-26.5%), $27.28 million in FY2022 (+54.9%) and $17.61 million in FY2021 (+212.6%).
- The Q4 2025 figure stands as the highest quarterly Gross Profit since Q3 2024.
- On a year-over-year basis, Gross Profit increased in two of the last eight quarters, with an average decline of 17.4%.
- The strongest year-over-year quarter for Gross Profit in the past five years was Q1 2025, with growth of 100.4%; the weakest was Q3 2025, with a decline of 82.5%.
- According to Business Quant data, Gross Profit for the three prior quarters was $706,000 (Q3 2025), $2.06 million (Q2 2025) and $3.62 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | CASI Pharmaceuticals | 2.47 Mn | -18.36 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 3.69 Mn |
| Sep 30, 2025 | 706,000.00 |
| Jun 30, 2025 | 2.06 Mn |
| Mar 31, 2025 | 3.62 Mn |
| Dec 31, 2024 | 3.23 Mn |
| Sep 30, 2024 | 4.05 Mn |
| Jun 30, 2024 | 2.07 Mn |
| Mar 31, 2024 | 1.81 Mn |
| Dec 31, 2023 | 4.06 Mn |
| Sep 30, 2023 | 5.19 Mn |
| Jun 30, 2023 | 5.83 Mn |
| Mar 31, 2023 | 4.97 Mn |
| Dec 31, 2022 | 10.99 Mn |
| Sep 30, 2022 | 5.97 Mn |
| Jun 30, 2022 | 5.02 Mn |
| Mar 31, 2022 | 5.30 Mn |
API Access
CASI Pharmaceuticals Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=CASIF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "CASIF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=CASIF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();